Latest Headlines

  1. Biomarkers, Vaccines And Personalized Medicine Hot Topics At 2010 BIO International Convention
    3/30/2010
    The 2010 BIO International Convention will feature a robust health and medical program highlighting the latest scientific breakthroughs and policy and business development issues that impact drug discovery and development
  2. NeurOp Announces Drug Discovery Collaboration With Bristol-Myers Squibb
    3/30/2010
    NeurOp Corporation recently announced a collaboration with Bristol-Myers Squibb Company focused upon the development of NeurOp's proprietary small molecules for use in the treatment of major depression and other central nervous system disorders
  3. Freeze Drying Of Pharmaceuticals: Principles And Practice Seminars
    3/30/2010
    SP Scientific has announced further updates for its 2010 Seminar Roadshow 'Freeze Drying of Pharmaceuticals: Principles and Practice'.
  4. Emory University School Of Medicine And Zirus, Inc. Team Up To Create New Class Of Anti-Viral Drugs
    3/29/2010
    The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease
  5. NexMed Files Investigational New Drug Application With FDA For Cancer Drug Candidate
    3/29/2010
    NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT technology, today announced that the Company has filed an Investigational New Drug (IND) application with the U.S. Food & Drug Administration (FDA) for a Phase II trial of its recently acquired cancer drug candidate PrevOnco, in combination with doxorubicin in patients with advanced, unresectable hepatocellular carcinoma (HCC).
  6. BioSolveIT And CCDC Release World Class Fragments For Top Quality Drug design
    3/24/2010
    BioSolveIT GmbH in conjunction with The Cambridge Crystallographic Data Centre (CCDC) recently announced the release of an exclusive set of fragments for 3D-based computational drug design. The Cambridge Structural Database (CSD) is a key global source for crystal structures and a major resource for the chemical and pharmaceutical industries
  7. NexMed, Inc. Enters Into Distribution Agreement For Japan
    3/23/2010
    NexMed, Inc., a company with a revenue generating discovery pre-clinical CRO and a pipeline of products based on the NexACT technology, recently announced that its wholly-owned subsidiary, Bio-Quant has signed a distribution agreement with Cosmo Bio Co., Ltd, under which Cosmo Bio will market Bio-Quant's discovery and pre-clinical contract research services throughout Japan
  8. ACS Webinar Focuses On Innovative Computational Methods In Drug Discovery
    3/12/2010
    News media and others interested in the chemical sciences are invited to join the next in a series of American Chemical Society (ACS) Webinars, focusing on Professional Growth and Development.
  9. Cellzome Announces Second Major Strategic Drug Discovery Alliance With GlaxoSmithKline In Inflammatory Disease
    3/11/2010
    Cellzome today announced that it has formed a second strategic alliance with GlaxoSmithKline (GSK). This new collaboration gives GSK exclusive access to Cellzome's proprietary Episphere™ technology in the emerging field of epigenetics as applied to immunoinflammatory disease.
  10. Cellular Dynamics And Roche Conduct 'Stem Cells In Drug Discovery And Development' Workshop At The Society Of Toxicology Annual Meeting
    3/4/2010
    Cellular Dynamics International (CDI) and Hoffmann-La Roche Inc. (Roche) today announced a workshop to be held during the Society of Toxicology Annual Meeting in Salt Lake City, UT, on March 7 - 11

First 5 6 7 8 9 10 10 (Last)